Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript
SLN earnings call for the period ending June 30, 2021.
Stay updated with breaking news from Mark Rothera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SLN earnings call for the period ending June 30, 2021.
"The £81.2mln in cash, cash equivalents, and term deposits as of June 30, 2021 positions us well to advance our proprietary technology platform."
IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca | Financial News
SLN124 was safe and effective in reducing plasma iron levels and had a long duration of action
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...